Agilent Technologies Inc. (A) News
Filter A News Items
A News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
A News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest A News From Around the Web
Below are the latest news stories about AGILENT TECHNOLOGIES INC that investors may wish to consider to help them evaluate A as an investment opportunity.
Agilent Technologies (A) Rebounded in Q3 Following an Encouraging Earnings ReleaseImpax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The MSCI All Country World Index (MSCI ACWI), which measures global equities, saw gains throughout the quarter as monetary easing by the US and Chinese central banks […] |
Jim Cramer on Agilent Technologies, Inc. (A): ‘They Told A Pretty Good Story’We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Agilent Technologies, Inc. (NYSE:A) stands against the other stocks. Jim Cramer, the host of Mad Money, recently shared some investment guidelines based on his 40 years of experience. As we previously […] |
Agilent (A) Up 1.3% Since Last Earnings Report: Can It Continue?Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Is the Options Market Predicting a Spike in Agilent (A) Stock?Investors need to pay close attention to Agilent (A) stock based on the movements in the options market lately. |
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceSANTA CLARA, Calif., December 19, 2024--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14, 2025, at 9:45 a.m. Pacific time. |
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR CertificationSANTA CLARA, Calif., December 10, 2024--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IHC 28-8 pharmDx (Code SK005). This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR) 1. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the Agilent Autost |
Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?A's shares ride on the bright performance of the Agilent CrossLab Group segment and strategic acquisitions. |
International Markets and Agilent (A): A Deep Dive for InvestorsExamine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock. |
These Stocks Moved the Most Today: GM, Amgen, Lilly, Super Micro, Best Buy, Rivian, NRG Energy, Kohl’s, and MoreShares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as weight-loss drug data disappoints Wall Street. |
Agilent Q4 Earnings Surpass Estimates, Revenues Increase Y/YA's fourth-quarter 2024 results benefit from strong demand in the ACG segment. However, declining sales in the Americas and China markets raise concerns. |